N-SUBSTITUTED AND 2-SUBSTITUTED N-(PHENYLSULFONYL)GLYCINES AS INHIBITORS OF RAT LENS ALDOSE REDUCTASE

被引:29
作者
DERUITER, J [1 ]
BORNE, RF [1 ]
MAYFIELD, CA [1 ]
机构
[1] UNIV MISSISSIPPI,SCH PHARM,DEPT MED CHEM,UNIVERSITY,MS 38677
关键词
D O I
10.1021/jm00121a027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:145 / 151
页数:7
相关论文
共 24 条
[11]  
DVORNIK D, 1987, ALDOSE REDUCTASE INH
[12]  
GREENE DA, 1987, NEW ENGL J MED, V316, P599
[13]   DECREASED MYOINOSITOL CONTENT AND NA+-K+-ATPASE ACTIVITY IN SUPERIOR CERVICAL-GANGLION OF STZ-DIABETIC RAT AND PREVENTION BY ALDOSE REDUCTASE INHIBITION [J].
GREENE, DA ;
MACKWAY, AM .
DIABETES, 1986, 35 (10) :1106-1108
[14]   ACTION OF SORBINIL IN DIABETIC PERIPHERAL-NERVE - RELATIONSHIP OF POLYOL (SORBITOL) PATHWAY INHIBITION TO A MYO-INOSITOL-MEDIATED DEFECT IN SODIUM-POTASSIUM ATPASE ACTIVITY [J].
GREENE, DA ;
LATTIMER, SA .
DIABETES, 1984, 33 (08) :712-716
[15]   THE PHARMACOLOGY OF ALDOSE REDUCTASE INHIBITORS [J].
KADOR, PF ;
ROBISON, WG ;
KINOSHITA, JH .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1985, 25 :691-714
[16]  
KADOR PF, 1981, EUR J MED CHEM, V16, P293
[17]   ALDOSE REDUCTASE INHIBITORS - A POTENTIAL NEW CLASS OF AGENTS FOR THE PHARMACOLOGICAL CONTROL OF CERTAIN DIABETIC COMPLICATIONS [J].
KADOR, PF ;
KINOSHITA, JH ;
SHARPLESS, NE .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (07) :841-849
[18]  
KADOR PF, 1983, MOL PHARMACOL, V24, P521
[19]  
KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713
[20]  
KINOSHITA JH, 1976, JPN J OPHTHALMOL, V20, P399